Dianthus Therapeutics (DNTH) Receivables (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Receivables of $102000.0 for Q4 2025, down 49.0% year-over-year from $200000.0 in Q4 2024, and down 98.0% quarter-over-quarter from $5.1 million in Q3 2025.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Receivables (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Receivables history runs 4 years deep, the most recent figure standing at $102000.0 for Q4 2025.
- In Q4 2025, Receivables fell 49.0% year-over-year to $102000.0; the TTM figure through Dec 2025 stood at $102000.0 (down 49.0% YoY), while the FY2025 annual figure was $102000.0, down 93.65% from the prior year.
- Receivables for Q4 2025 stood at $102000.0, down from $5.1 million in the prior quarter.
- The five-year high for Receivables was $5.6 million in Q4 2022, with the low at $102000.0 in Q4 2025.
- The 4-year median for Receivables is $835000.0 (2024), against an average of $1.7 million.
- The sharpest annual moves came in 2024 and 2025: Receivables soared 259.52% in 2024, then plunged 91.52% in 2025.
- Dianthus Therapeutics' Receivables stood at $5.6 million in 2022, then slumped by 91.07% to $500000.0 in 2023, then slumped by 60.0% to $200000.0 in 2024, then plunged by 49.0% to $102000.0 in 2025.
- Business Quant data shows DNTH's Receivables at $102000.0 in Q4 2025, $5.1 million in Q3 2025, and $139000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 160.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.06 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - | 102,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 835,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 751,000.00 |
| Dec 31, 2022 | 5.60 Mn |